Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Now watching

Next video starts in : 7 Play

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People
Replay video
Up next

Hillary Clinton Responds to Email Controversy

Unlock your personal NFL Now stream by signing in to NFL.com

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

by TheStreet.com Videos 1:02 mins

New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York.

View Comments (0)